secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2023-01-25T23:59:59+00:00
Accession:  0001193125-23-015276
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics launches $250M equity offering; prelim cash $331.2M
-----------------------------------------------------------------------

- Preliminary cash, equivalents and short-term investments of $331.2M as of Dec 31, 2022 (unaudited).
- Public offering of 8.33M shares at $30/share; gross proceeds ~$250M (or ~$287.5M if overallotment exercised).
- Underwriters: J.P. Morgan and Piper Sandler; offering expected to close Jan 27, 2023.
- Company also granted underwriters 30-day option for up to 1.25M additional shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000119312523015276/0001193125-23-015276-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000119312523015276/d455919d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-015276

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer